banner
Trk receptor inhibitor GNF 5837, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ373

Trk receptor inhibitor GNF 5837, Purity ≥98%

Synonym: 1033769-28-6; Trk receptor inhibitor; GNF-5837; GNF5837

  • MDL: MFCD24386809
  • CAS Number: 1033769-28-6
  • Compound CID: 59397065
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
GNF 5837, soluble in DMSO and warmed ethanol and insoluble in water, blocks the activity of tropomyosin receptor kinases, which are involved in the growth and survival of neurons. It targets TrkA, TrkB, Abl, ALK, CSF-1R, FGFR3, FGFR4, FLT3, IGF-1R, Insulin receptor, and JAK2.
Molecular Weight
535.49
Molecular Formula
C28H21F4N5O2
Targets
TrkA: 11 nM; TrkB: 9 nM; Abl: 8.2 nM; ALK: 3.4 nM; CSF-1R: 4 μM; FGFR3: 9.3 μM; FGFR4: 7 μM; FLT3: 5.1 μM; IGF-1R: 7.6 μM; Insulin receptor: 8 μM; JAK2: 2.9 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 92 mg/mL (171.8 mM); Water: Insoluble; Warmed ethanol: 8 mg/mL (14.93 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
GNF 5837 is examined for its role in inhibiting Trk kinases, relevant in researching treatments for cancers and neurological disorders.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0